Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Liu, D.S.

Concepts (32)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms220203580.760 Why?
Papillomaviridae220209810.530 Why?
Papillomavirus Infections2202011860.500 Why?
Lymphatic Metastasis1201830330.440 Why?
Neck Dissection220202040.230 Why?
Alphapapillomavirus120201070.210 Why?
Fluorodeoxyglucose F181201819210.110 Why?
Radiopharmaceuticals1201826140.090 Why?
Disease-Free Survival1201871260.090 Why?
Head and Neck Neoplasms1201824560.070 Why?
Carcinoma, Squamous Cell1201839080.060 Why?
Sensitivity and Specificity12018151300.060 Why?
Neoplasm Recurrence, Local1201878010.060 Why?
Skin Neoplasms1201850600.050 Why?
Follow-Up Studies12018386390.040 Why?
Retrospective Studies22020597640.040 Why?
Carboplatin120187880.040 Why?
Clinical Trials, Phase III as Topic120187430.040 Why?
Aged, 80 and over12018574690.030 Why?
Young Adult12018524540.030 Why?
Radiotherapy, Adjuvant1201818590.030 Why?
Radiotherapy Dosage1201828930.030 Why?
Postoperative Care1201815440.030 Why?
Aged220181552000.030 Why?
Middle Aged220182091700.020 Why?
Adult120182036580.020 Why?
Male220183409400.020 Why?
Female220183609480.020 Why?
Survival Rate12018131830.020 Why?
Neoplasm Staging12018110540.020 Why?
Humans320206446660.010 Why?
Randomized Controlled Trials as Topic1201888320.010 Why?
Liu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.